| Literature DB >> 30055250 |
Massimo Venturini1, Paolo Marra2, Anna Colarieti2, Giulia Agostini2, Carolina Lanza2, Luigi Augello2, Simone Gusmini2, Marco Salvioni2, Germano Melissano3, Paolo Fiorina4, Roberto Chiesa3, Francesco De Cobelli5, Alessandro Del Maschio5.
Abstract
Diabetes mellitus is associated with both microvascular and macrovascular complications, which can result in visceral aneurysms as for example splenic artery aneurysms: in their management, an endovascular treatment, less invasive than surgery, is generally preferred. Endovascular treatment of splenic artery aneurysms can be based either on covered stenting (CS) or transcatheter embolization (TE). CS generally allows aneurysm exclusion with vessel preservation, while TE usually determines target artery occlusion with potential risk of distal ischemia. We performed a review of the existing literature on endovascular treatment of visceral artery aneurysms (VAAs) and psudoaneurysms (VAPAs) in the current era.Entities:
Keywords: Covered stent; Diabetes; Endovascular treatment; Transcatheter embolization; Visceral aneurysm
Mesh:
Year: 2018 PMID: 30055250 DOI: 10.1016/j.phrs.2018.07.023
Source DB: PubMed Journal: Pharmacol Res ISSN: 1043-6618 Impact factor: 7.658